Ardent Health Partners (NYSE:ARDT) Stock Price Expected to Rise, Leerink Partners Analyst Says

Ardent Health Partners (NYSE:ARDT) had its price target increased by analysts at Leerink Partners from $23.00 to $25.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Leerink Partners’ price target indicates a potential upside of 46.97% from the company’s current price.

Other analysts have also issued reports about the stock. Bank of America lowered shares of Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Stephens reaffirmed an “overweight” rating and set a $24.00 price objective on shares of Ardent Health Partners in a research note on Thursday, September 19th. JPMorgan Chase & Co. initiated coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a “neutral” rating and a $18.00 price objective for the company. Royal Bank of Canada initiated coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set an “outperform” rating and a $23.00 price objective for the company. Finally, Leerink Partnrs raised shares of Ardent Health Partners to a “strong-buy” rating in a research note on Monday, August 12th. Two analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, Ardent Health Partners has an average rating of “Buy” and an average price target of $21.82.

Ardent Health Partners Stock Performance

NYSE:ARDT opened at $17.01 on Tuesday. Ardent Health Partners has a twelve month low of $14.57 and a twelve month high of $20.72. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The firm’s 50-day simple moving average is $18.27.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings data on Wednesday, August 14th. The company reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.05. The firm had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Analysts forecast that Ardent Health Partners will post 1.25 earnings per share for the current year.

Institutional Trading of Ardent Health Partners

Several institutional investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $42,000. Charles Schwab Investment Management Inc. acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $526,000. Financial Management Professionals Inc. acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $50,000. Allspring Global Investments Holdings LLC acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $13,119,000. Finally, Seven Grand Managers LLC acquired a new stake in Ardent Health Partners in the third quarter valued at approximately $2,298,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.